NovaBridge Biosciences
NBP
$3.21
-$0.03-0.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -20.18% | -44.38% | -44.38% | -- |
| Total Receivables | -- | -- | -36.06% | -36.06% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -94.60% | 822.13% | 822.13% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -93.85% | -93.85% | -- |
| Total Current Assets | -- | -27.26% | -46.44% | -46.44% | -- |
|
|
|||||
| Total Current Assets | -- | -27.26% | -46.44% | -46.44% | -- |
| Net Property, Plant & Equipment | -- | -13.00% | -31.62% | -31.62% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 162.72% | -95.92% | -95.92% | -- |
| Total Assets | -- | -18.56% | -42.35% | -42.35% | -- |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -- | -42.32% | 14.54% | 14.54% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 15.74% | 30.35% | 30.35% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -99.79% | -99.79% | -- |
| Total Other Current Liabilities | -- | -- | -99.79% | -99.79% | -- |
| Total Current Liabilities | -- | -47.42% | -85.46% | -85.46% | -- |
|
|
|||||
| Total Current Liabilities | -- | -47.42% | -85.46% | -85.46% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -18.44% | -5.98% | -5.98% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -- | -41.99% | -90.88% | -90.88% | -- |
|
|
|||||
| Common Stock & APIC | -- | 0.07% | -0.99% | -0.99% | -- |
| Retained Earnings | -- | -3.04% | -1.76% | -1.76% | -- |
| Treasury Stock & Other | -- | -7.77% | -14.50% | -14.50% | -- |
| Total Common Equity | -- | -16.86% | -17.08% | -17.08% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -- | -16.86% | -17.08% | -17.08% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -- | -16.86% | -17.08% | -17.08% | -- |
|
|
|||||